Robert Kratzke

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 26, 2026
STK11 as an Emerging Biomarker in Non-Small Cell Lung Cancer.

|Feb 13, 2026
Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Oct 19, 2025
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.

Timothy A Yap, David J Kwiatkowski, Ibiayi Dagogo-Jack

|Aug 29, 2024
Serum Splicing Factor Proline- and Glutamine-Rich Is a Diagnostic Marker for Non-Small-Cell Lung Cancer and Other Solid Cancers.

Libang Yang, Adam Gilbertsen, Blake Jacobson

|Aug 12, 2023
SFPQ and Its Isoform as Potential Biomarker for Non-Small-Cell Lung Cancer.

Libang Yang, Adam Gilbertsen, Blake Jacobson

|Nov 24, 2020
4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.

Blake A Jacobson, Zeeshan Ahmad, Sierra Chen

Pageof 2

Frequent Collaborators

1 joint publications

Amit A Kulkarni

1 joint publications

Naomi Fujioka

1 joint publications

Pankaj Gupta

1 joint publications

Niveditha Subbiah